Mr. Robert Kaul reports

CLOUD DX RECEIVES $770,000 ORDER FOR NEW TECHNOLOGY DEVICES AND SERVICES

On Feb. 6, 2024, Cloud Dx Inc. received a purchase order for up to 300 advanced Vitaliti continuous vital sign monitor systems and related software, valued at approximately $770,000. As of Sept. 30, 2023, Cloud DX reported gross margins of approximately 77 per cent.

The units will be manufactured at the company's Kitchener, Ont., facility and are expected to be delivered by the end of Q2 2024. The purchase order specifies a 50-per-cent deposit, with the balance to be paid upon delivery.

These patented and patent-pending Vitaliti units are expected to be deployed in multisite studies of postoperative patients, with the first conducted under a Health Canada ITA (investigational testing authorization) in advance of full Health Canada licence and FDA clearance. Patients will be followed at home after surgery, and Vitaliti data will be used to train generative artificial intelligence (AI) algorithms that are expected to predict and avoid adverse health care outcomes.

Vitaliti is the subject of peer-reviewed academic papers, demonstrating the system's accuracy when measuring continuous non-invasive blood pressure and its competitive place in the continuous multiparameter monitoring landscape, respectively, including: "Continuous Noninvasive Remote Automated Blood Pressure Monitoring with Novel Wearable Technology: A Preliminary Validation Study," JMIR mHealth and uHealth, Volume 10, No. 2 (February, 2022); and "Beyond Wellness Monitoring: Continuous Multiparameter Remote Automated Monitoring of Patients," Canadian Journal of Cardiology, Volume 38, Issue 2, pages 267 to 278, February, 2022.

Vitaliti facts: Each lightweight Vitaliti system consists of a main unit that attaches to the chest, ECG (electrocardiography) leads and an advanced earpiece with multiple sensors for heart rate, pulse oxygen and temperature; up to 72 hours of continuous use; advanced two-lead ECG with three additional leads for full five-lead ECG data; continuous non-invasive blood pressure without a cuff; pulse oxygen, heart rate, respiration rate, core body temperature and three-axis accelerometer and gyroscope data; and generative AI algorithms that can detect cardiac anomalies and atrial fibrillation and predict negative health outcomes in time for clinicians to intervene. Vitaliti is designed to complement the best-in-class Cloud DX Connected Health kits now used for periodic monitoring of vital signs and comprehensive virtual care across North America.

So far in 2024, Cloud DX has announced seven contracts/orders valued in excess of $2.5-million, including with Health PEI, Markham Stouffville Hospital and VHA Home HealthCare.

Cloud DX chief executive officer and founder Robert Kaul stated: "This initial order for advanced Vitaliti CVSM systems is an important milestone for Cloud DX. We first introduced Vitaliti as the core element of our XPrize-winning Tricorder in 2017. We then went back to a clean sheet of paper and redesigned Vitaliti to become one of the most accurate and effective continuous vital sign monitor solutions in the world. This first deployment of Vitaliti in a highly regarded, multisite, multiyear clinical study will move forward the state of the art in virtual care while also gathering data required for Health Canada and FDA [U.S. Food and Drug Administration] regulatory approvals."

Investor conference videos now available

Mr. Kaul presented a webinar on Jan. 17, 2024, at 4 p.m. Eastern Time (United States and Canada). A recording of his presentation can be seen on-line.

The Maxim Group (NYC) held its annual health care IT (information technology) virtual conference on Wednesday, Jan. 24, 2024, with 18 companies presenting. Investors can see the Cloud DX presentation on-line.

About Cloud DX Inc.

Accelerating digital health care, Cloud DX is on a mission to make health care better for everyone. The company's Connected Health remote patient monitoring platform is used by health care enterprises and care teams across North America to virtually manage chronic disease, enable aging in place and deliver hospital-quality postsurgical care in the home. The company's partners achieve better health care and patient outcomes, reduce the need for hospitalization or readmission, and reduce health care delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPrize, the winner of 2022 Top Innovator from Canadian Business, a 2021 Edison Award winner, a Fast Company World Changing Idea finalist and one of Canada's Ten Most Prominent Telehealth Providers. Cloud DX is an exclusive partner to Medtronic Canada and Teladoc Health Canada.

We seek Safe Harbor.